GUGGENHEIM CAPITAL LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,089,820
-23.2%
40,559
+2.0%
0.01%
-18.2%
Q2 2023$1,418,234
+18.9%
39,771
-15.3%
0.01%
+10.0%
Q1 2023$1,193,114
-37.5%
46,973
-0.3%
0.01%
-41.2%
Q4 2022$1,910,498
+20.0%
47,103
-2.2%
0.02%
+13.3%
Q3 2022$1,592,000
-20.3%
48,161
-15.2%
0.02%
-6.2%
Q2 2022$1,998,000
-23.8%
56,763
-0.5%
0.02%0.0%
Q1 2022$2,623,000
-22.0%
57,036
+12.4%
0.02%
-11.1%
Q4 2021$3,363,000
+2.8%
50,729
-3.1%
0.02%
-10.0%
Q3 2021$3,270,000
-18.5%
52,373
+8.2%
0.02%
-16.7%
Q2 2021$4,010,000
+12.5%
48,421
-9.9%
0.02%
+4.3%
Q1 2021$3,565,000
-9.4%
53,765
+4.8%
0.02%
-8.0%
Q4 2020$3,937,000
+2.3%
51,313
-42.6%
0.02%
-10.7%
Q3 2020$3,850,000
-15.0%
89,421
-14.7%
0.03%
-20.0%
Q2 2020$4,530,000
+110.0%
104,886
+39.9%
0.04%
+59.1%
Q1 2020$2,157,000
-59.1%
74,972
-9.8%
0.02%
-45.0%
Q4 2019$5,274,000
+2035.2%
83,154
+847.3%
0.04%
+1900.0%
Q3 2019$247,000
+13.3%
8,778
+6.9%
0.00%0.0%
Q2 2019$218,0008,2120.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders